Plaque Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Plaque Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Report Format: PDF+Excel | Report ID: SR112024A7500
Buy Now

 Market Overview:

The 7 major plaque psoriasis markets are expected to exhibit a CAGR of 4.2% during 2023-2033.

The plaque psoriasis market has been comprehensively analyzed in IMARC's new report titled "Plaque Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033". Plaque psoriasis is a chronic autoimmune disease characterized by the formation of raised, red, scaly skin patches known as plaques. These plaques can vary in size and location but are typically found on the elbows, knees, scalp, and lower back. They can be itchy, painful, uncomfortable, and even bleed in severe cases. Various other symptoms may include dry and cracked skin, joint pain or stiffness, nail changes like pitting or separation from the nail bed, etc. In addition to the physical indications, the ailment can significantly impact a person's mental health and quality of life, causing embarrassment, social isolation, and depression. The diagnosis of plaque psoriasis involves a physical examination of the affected skin, including an assessment of the size, shape, and location of the plaques. A doctor may also ask about family history, medical history, and any other symptoms the patient may be experiencing. In some cases, a skin biopsy is necessary to confirm the diagnosis. Numerous other procedures, such as blood tests, joint X-rays, or a skin scraping to check for fungal infection, may be recommended if there are concerns about related conditions or further possible causes of symptoms.

Plaque Psoriasis Market

The increasing cases of immune system dysfunction in which the immune system mistakenly attacks healthy skin cells, leading to inflammation and the formation of plaques, are primarily driving the plaque psoriasis market. Moreover, the escalating utilization of Vitamin D analogs, such as calcipotriene and calcitriol, for reducing the severity of disease symptoms, including scaling, redness, itching, etc., and decreasing the thickness of plaques is further augmenting the market growth. Besides this, the widespread adoption of phototherapy as a treatment option since it is well-tolerated, helps to prevent flare-ups, and improves skin texture is also creating a positive outlook for the market. Furthermore, various key players are making extensive investments in developing novel therapies to manage cytokines and other immune system proteins that promote skin inflammation and the formation of psoriatic plaques. This, in turn, is acting as another significant growth-inducing factor. Additionally, the inflating demand for biologics, which target specific proteins in the immune system to reduce inflammation, for treating moderate to severe psoriasis that has not responded to other treatments, is expected to drive the plaque psoriasis market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the plaque psoriasis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for plaque psoriasis and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the plaque psoriasis market in any manner.

Time Period of the Study

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033
     

Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the plaque psoriasis market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the plaque psoriasis market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current plaque psoriasis marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     
Drugs Company Name
Duobrii (Tazarotene/ulobetasol) Ortho Dermatologics
Siliq (Brodalumab) AstraZeneca/Bausch Health Companies/Kyowa Kirin/LEO Pharma
Ilumya (Tildrakizumab) Almirall/Sun Pharmaceutical Industries
Zoryve (Roflumilast topical) Arcutis Biotherapeutics
Enbrel (Etanercept) Pfizer
ABY 035 Affibody
AK 101 Akeso Biopharma
ESK001 Alumis Inc
TLL018 Hangzhou Highlightll Pharmaceutical
JNJ 77242113 Janssen Biotech


*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

  • How has the plaque psoriasis market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the plaque psoriasis market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the plaque psoriasis market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the number of prevalent cases (2017-2033) of plaque psoriasis across the seven major markets?
  • What is the number of prevalent cases (2017-2033) of plaque psoriasis by age across the seven major markets?
  • What is the number of prevalent cases (2017-2033) of plaque psoriasis by gender across the seven major markets?
  • How many patients are diagnosed (2017-2033) with plaque psoriasis across the seven major markets?
  • What is the size of the plaque psoriasis patient pool (2017-2022) across the seven major markets?
  • What would be the forecasted patient pool (2023-2033) across the seven major markets?
  • What are the key factors driving the epidemiological trend of plaque psoriasis?
  • What will be the growth rate of patients across the seven major markets?
     

Plaque Psoriasis: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for plaque psoriasis drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the plaque psoriasis market?
  • What are the key regulatory events related to the plaque psoriasis market?
  • What is the structure of clinical trial landscape by status related to the plaque psoriasis market?
  • What is the structure of clinical trial landscape by phase related to the plaque psoriasis market?
  • What is the structure of clinical trial landscape by route of administration related to the plaque psoriasis market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Plaque Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More